Wei JT - Search Results

1

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.

Mosquera JM, Mehra R, Regan MM, Perner S, Genega EM, Bueti G, Shah RB, Gaston S, Tomlins SA, Wei JT, Kearney MC, Johnson LA, Tang JM, Chinnaiyan AM, Rubin MA, Sanda MG. Mosquera JM, et al. Among authors: wei jt. Clin Cancer Res. 2009 Jul 15;15(14):4706-11. doi: 10.1158/1078-0432.CCR-08-2927. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584163 Free PMC article.

2

Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer.

Marcovich R, Wojno KJ, Wei JT, Rubin MA, Montie JE, Sanda MG. Marcovich R, et al. Among authors: wei jt. Urology. 2000 Jun;55(6):904-8. doi: 10.1016/s0090-4295(00)00451-9. Urology. 2000. PMID: 10840106

3

Prospective assessment of patient reported urinary continence after radical prostatectomy.

Wei JT, Dunn RL, Marcovich R, Montie JE, Sanda MG. Wei JT, et al. J Urol. 2000 Sep;164(3 Pt 1):744-8. doi: 10.1097/00005392-200009010-00029. J Urol. 2000. PMID: 10953138

4

Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features.

Hollenbeck BK, Bassily N, Wei JT, Montie JE, Hayasaka S, Taylor JM, Rubin MA. Hollenbeck BK, et al. Among authors: wei jt. J Urol. 2000 Nov;164(5):1583-6. J Urol. 2000. PMID: 11025709

5

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.

Shah R, Bassily N, Wei J, Mucci NR, Montie JE, Sanda MG, Rubin MA. Shah R, et al. Urology. 2000 Nov 1;56(5):721-5. doi: 10.1016/s0090-4295(00)00775-5. Urology. 2000. PMID: 11068287

6

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Wei JT, et al. Urology. 2000 Dec 20;56(6):899-905. doi: 10.1016/s0090-4295(00)00858-x. Urology. 2000. PMID: 11113727

7

Assessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairment.

Kielb S, Dunn RL, Rashid MG, Murray S, Sanda MG, Montie JE, Wei JT. Kielb S, et al. Among authors: wei jt. J Urol. 2001 Sep;166(3):958-61. J Urol. 2001. PMID: 11490254

8

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG. Wei JT, et al. J Clin Oncol. 2002 Jan 15;20(2):557-66. doi: 10.1200/JCO.2002.20.2.557. J Clin Oncol. 2002. PMID: 11786586

9

Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy.

Hollenbeck BK, Dunn RL, Wei JT, McLaughlin PW, Han M, Sanda MG. Hollenbeck BK, et al. Among authors: wei jt. Urology. 2002 Apr;59(4):480-4. doi: 10.1016/s0090-4295(01)01664-8. Urology. 2002. PMID: 11927294

10

Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.

Miller DC, Litwin MS, Sanda MG, Montie JE, Dunn RL, Resh J, Sandler H, Wei JT. Miller DC, et al. Among authors: wei jt. Cancer. 2003 Mar 15;97(6):1428-35. doi: 10.1002/cncr.11216. Cancer. 2003. PMID: 12627506 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters